Clarus Therapeutics Holdings Inc. Made Headway

Wed, Apr 20, 2022 at 05:30 PM
Clarus Therapeutics Holdings Inc. Made Headway

Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ) rocketted at $2.08, representing a gain of 43.4%. On Tue, Apr 19, 2022, CRXT:NASDAQ hit a New 2-Week High of $1.45. The stock appeared on our News Catalysts scanner on Tue, Apr 19, 2022 at 10:21 AM in the 'MISCELLANEOUS' category. From Wed, Apr 06, 2022, the stock recorded 42.86% Up Days and 25.00% Green Days

The stock spiked on Thu, Apr 14, 2022 at $1.7 with a volume of 88M+.

About Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ)

Clarus Therapeutics Holdings Inc is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.